These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 30031227)

  • 1. Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.
    Tramutola A; Sharma N; Barone E; Lanzillotta C; Castellani A; Iavarone F; Vincenzoni F; Castagnola M; Butterfield DA; Gaetani S; Cassano T; Perluigi M; Di Domenico F
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3309-3321. PubMed ID: 30031227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome.
    Zuliani I; Lanzillotta C; Tramutola A; Francioso A; Pagnotta S; Barone E; Perluigi M; Di Domenico F
    Neurotherapeutics; 2021 Jan; 18(1):340-363. PubMed ID: 33258073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
    Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
    Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain.
    Förster S; Welleford AS; Triplett JC; Sultana R; Schmitz B; Butterfield DA
    Biochim Biophys Acta; 2014 Sep; 1842(9):1333-9. PubMed ID: 24859566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAcylation and neurodegeneration.
    Wani WY; Chatham JC; Darley-Usmar V; McMahon LL; Zhang J
    Brain Res Bull; 2017 Jul; 133():80-87. PubMed ID: 27497832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
    Yuzwa SA; Vocadlo DJ
    Chem Soc Rev; 2014 Oct; 43(19):6839-58. PubMed ID: 24759912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies.
    Pinho TS; Correia SC; Perry G; Ambrósio AF; Moreira PI
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2048-2059. PubMed ID: 30412792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain.
    Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
    PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.
    Liu F; Shi J; Tanimukai H; Gu J; Gu J; Grundke-Iqbal I; Iqbal K; Gong CX
    Brain; 2009 Jul; 132(Pt 7):1820-32. PubMed ID: 19451179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genetic model to study
    St Amand MM; Bond MR; Riedy J; Comly M; Shiloach J; Hanover JA
    J Biol Chem; 2018 Aug; 293(35):13673-13681. PubMed ID: 29954943
    [No Abstract]   [Full Text] [Related]  

  • 11. Hexosamine biosynthetic pathway and
    Kim DY; Park J; Han IO
    Am J Physiol Cell Physiol; 2023 Oct; 325(4):C981-C998. PubMed ID: 37602414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
    Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
    PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
    Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
    Gong CX; Liu F; Iqbal K
    Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protein O-GlcNAcylation and regulation of cell signalling: involvement in pathophysiology].
    Issad T; Pagesy P
    Biol Aujourdhui; 2014; 208(2):109-17. PubMed ID: 25190571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease.
    Dos Santos JPA; Vizuete A; Hansen F; Biasibetti R; Gonçalves CA
    J Alzheimers Dis; 2018; 61(1):237-249. PubMed ID: 29154269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.
    Park J; Lai MKP; Arumugam TV; Jo DG
    Neuromolecular Med; 2020 Jun; 22(2):171-193. PubMed ID: 31894464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAcylation, a sweet link to the pathology of diseases.
    Nie H; Yi W
    J Zhejiang Univ Sci B; 2019 May; 20(5):437-448. PubMed ID: 31090269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained
    Tan EP; McGreal SR; Graw S; Tessman R; Koppel SJ; Dhakal P; Zhang Z; Machacek M; Zachara NE; Koestler DC; Peterson KR; Thyfault JP; Swerdlow RH; Krishnamurthy P; DiTacchio L; Apte U; Slawson C
    J Biol Chem; 2017 Sep; 292(36):14940-14962. PubMed ID: 28739801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.